[Paracetamol dosage for children--different from that for adults]

Related Experiment Video

Updated: Aug 15, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Kaspar Buus Jensen1, Kim P Dalhoff

  • 1H:S Rigshospitalet, Klinisk Farmakologisk Afdeling, København Ø. buus@dadlnet.dk

Ugeskrift for Laeger
|October 13, 2005
PubMed

Insights

Paracetamol (acetaminophen) is a common children's medicine, but its use in pediatric patients differs from adults. This review examines guidelines and evidence for pediatric paracetamol use.

Area of Science:

  • Pediatric Pharmacology
  • Drug Safety and Efficacy

Background:

  • Paracetamol (acetaminophen) is the most frequently used antipyretic and analgesic medication for children in Denmark.
  • A significant gap exists between paracetamol consumption in children and the understanding of their specific pharmacokinetic and pharmacodynamic profiles.
  • Dosage, therapeutic windows, and toxicity of paracetamol vary between pediatric and adult populations.

Purpose of the Study:

  • To review current published guidelines for pediatric paracetamol (acetaminophen) administration.
  • To evaluate the evidence base supporting existing guidelines for treating children with paracetamol.
  • To highlight discrepancies in pediatric paracetamol usage and knowledge.

Main Methods:

  • Systematic review of published literature.
  • Analysis of existing clinical guidelines for pediatric paracetamol use.
  • Evidence-based assessment of pharmacokinetic and pharmacodynamic data in children.

Main Results:

  • Identified widespread use of paracetamol in Danish children.
  • Documented a lack of comprehensive pharmacokinetic and pharmacodynamic data specific to pediatric populations.
  • Highlighted variations in dosage, therapeutic intervals, and toxic potential between children and adults.

Conclusions:

  • There is a need for more research into pediatric paracetamol pharmacokinetics and pharmacodynamics.
  • Guidelines for pediatric paracetamol use require robust evidence to ensure safe and effective treatment.
  • Further investigation is warranted to align paracetamol usage with established pediatric evidence.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...